RFA
BIIB icon

Reilly Financial Advisors’s Biogen BIIB Stock Holding History

Reilly Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-895
Closed -$274K – 1199
2015
Q4 		$274K Buy
+895
New +$257K 0.05% 157

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Reilly Financial Advisors's BIIB Position: Q4 2021 in Review

Reilly Financial Advisors held its Biogen (BIIB) position steady in Q4 2021 at 55 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Reilly Financial Advisors first reported a position in BIIB in Q2 2013 and has held it in 34 quarters since. The position peaked at $378K in Q1 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Reilly Financial Advisors held 55 shares of Biogen worth $13K as of Q4 2021.
  • Reilly Financial Advisors left its Biogen share count unchanged in Q4 2021.
  • Biogen made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #654 holding.
  • Reilly Financial Advisors first reported a position in Biogen in Q2 2013 and has held it in 34 quarters since.
  • Reilly Financial Advisors's Biogen position peaked at $378K in Q1 2015.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.